Clinical Trials Directory

Trials / Completed

CompletedNCT02031016

Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain

A Randomised Clinical Trial Evaluating the Effect of Remifentanil vs Fentanyl During Cardiac Surgery on the Incidence of Chronic Thoracic Pain

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
126 (actual)
Sponsor
St. Antonius Hospital · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the influence of intra-operative use of remifentanil versus fentanyl on the percentage of patients with chronic thoracic after cardiac surgery via sternotomy. Secondary quantitative sensory testing is performed to determine thermal and electrical detection and pain threshold and the difference in pain variability scoring. Postoperative pain scores, analgesic use, genetic variances and costs are measured.

Conditions

Interventions

TypeNameDescription
DRUGFentanylfentanyl bolus injections on an "as needed" base, NEXT TO the fentanyl bolus injections on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.
DRUGRemifentanilstarting with 0.15 ug/IBW(kg)/min, next to fentanyl bolus injections (200-500 ug) on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.
DRUGFentanylfentanyl bolus injections on predetermined times; before incision, at sternotomy, at aorta canulation and at opening of the pericardium.

Timeline

Start date
2014-02-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2014-01-09
Last updated
2016-10-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02031016. Inclusion in this directory is not an endorsement.